Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alirocumab 150mg/1ml inj pre-filled disposable devices
0212000AIAAABAB
|
Alirocumab | Alirocumab | Cardiovascular System | 30 |
|
Felotens XL 5mg tablets
0206020F0BEAAAB
|
Felotens | Felodipine | Cardiovascular System | 30 |
|
Loniten 10mg tablets
0205010N0BBACAC
|
Loniten | Minoxidil | Cardiovascular System | 30 |
|
Ramipril 10mg/5ml oral suspension
0205051R0AAAWAW
|
Ramipril | Ramipril | Cardiovascular System | 30 |
|
Adrenaline (base) 100microg/1ml (1 in 10,000) dilute inj amp
0207030A0AAADAD
|
Adrenaline (Parenteral) | Adrenaline | Cardiovascular System | 29 |
|
Felotens XL 10mg tablets
0206020F0BEABAC
|
Felotens | Felodipine | Cardiovascular System | 29 |
|
Losartan 100mg/5ml oral liquid
0205052N0AAAFAF
|
Losartan potassium | Losartan potassium | Cardiovascular System | 29 |
|
Metoprolol 12.5mg/5ml oral solution
0204000K0AABKBK
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | 29 |
|
Nifedipress MR 20 tablets (Teva)
0206020R0CBAEAR
|
Nifedipress | Nifedipine | Cardiovascular System | 29 |
|
Raporsin XL 4mg tablets (Actavis)
0205040D0BKAAAQ
|
Raporsin | Doxazosin mesilate | Cardiovascular System | 29 |
|
Chlorothiazide 150mg/5ml oral suspension
0202010D0AADDDD
|
Chlorothiazide | Chlorothiazide | Cardiovascular System | 28 |
|
Kerendia 10mg tablets
0202030Y0BBAAAA
|
Kerendia | Finerenone | Cardiovascular System | 28 |
|
Revatio 10mg/ml oral suspension
0205010Y0BBABAB
|
Revatio | Sildenafil(Vasodilator Antihypertensive) | Cardiovascular System | 28 |
|
Corgard 80mg tablets
0204000M0BBABAB
|
Corgard | Nadolol | Cardiovascular System | 27 |
|
Lisinopril 7.5mg/5ml oral liquid
0205051L0AAANAN
|
Lisinopril | Lisinopril | Cardiovascular System | 27 |
|
Loniten 5mg tablets
0205010N0BBABAB
|
Loniten | Minoxidil | Cardiovascular System | 27 |
|
Ramipril 10mg/5ml oral solution
0205051R0AAAHAH
|
Ramipril | Ramipril | Cardiovascular System | 27 |
|
Captopril 25mg/5ml oral liquid
0205051F0AABWBW
|
Captopril | Captopril | Cardiovascular System | 26 |
|
Efient 5mg tablets
0209000Y0BBAAAA
|
Efient | Prasugrel | Cardiovascular System | 26 |
|
Lipozate 400mg modified-release tablets
0212000D0BGAAAB
|
Lipozate | Bezafibrate | Cardiovascular System | 26 |
|
Sacubitril 6mg / Valsartan 6mg gran in caps for opening
0205052AEAAADAD
|
Sacubitril/valsartan | Sacubitril/valsartan | Cardiovascular System | 26 |
|
Tinzaparin sodium 40,000units/2ml inj vials
0208010W0AAAFAF
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 26 |
|
Arixtra 7.5mg/0.6ml inj pre-filled syringes
0208010ABBBACAC
|
Arixtra | Fondaparinux sodium | Cardiovascular System | 25 |
|
Arovi 20mg/0.2ml solution for injection pre-filled syringes
0208010D0BEAAAA
|
Arovi | Enoxaparin | Cardiovascular System | 25 |
|
Alirocumab 75mg/1ml inj pre-filled disposable devices
0212000AIAAAAAA
|
Alirocumab | Alirocumab | Cardiovascular System | 24 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.